End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
85,100 KRW | +0.59% |
|
-7.70% | +67.85% |
07-04 | HLB Stock Soars Amid FDA Re-Approval Efforts for Liver Cancer Drug | MT |
06-25 | HLB Co., Ltd. announced that it expects to receive KRW 33 billion in funding from F&F Co., Ltd | CI |
1st Jan change | Capi. | |
---|---|---|
+67.85% | 8.04B | |
-6.46% | 179B | |
-6.43% | 98.84B | |
-7.28% | 65.34B | |
+15.46% | 45.41B | |
-8.93% | 44.94B | |
+8.19% | 43.76B | |
+12.00% | 29.01B | |
+19.39% | 25.65B | |
-9.09% | 23.32B |
- Stock Market
- Equities
- A028300 Stock
- News HLB Co., Ltd.
- HLB Stock Soars Amid FDA Re-Approval Efforts for Liver Cancer Drug